Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

New A-homo-B, 19-dinor steroids showed strong antiandrogenic activity without affecting the enzyme 5α-reductase or androgen receptor binding.

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

Active oxygen scavengers can reverse the suppression of hair cell growth caused by androgens.

Male sexual differentiation is regulated independently, while female differentiation occurs in an androgenic environment, affecting conditions like congenital adrenal hyperplasia.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

The enzyme 5α-reductase is important for proper blood vessel development during the fertility-related transformation of the uterus lining.

Androgenetic alopecia in males is linked to hormone levels and the enzyme 5-alpha reductase.

Androgen is important in controlling stem cell differentiation, reducing fat development, and increasing lean mass.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Oxidative stress plays a role in female pattern baldness, causing an imbalance between harmful and protective elements in the body.

Oral 5-alpha-reductase inhibitors for hair loss don't increase heart risk.

Minoxidil can reduce functions related to androgen receptors.

Honokiol might help reduce male skin aging by maintaining testosterone levels.

Testosterone's muscle-building effects do not require its conversion to DHT.

5α-Reductase inhibitors don't cause depression.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Some men's prostate tissues have low enzyme levels due to genetic changes, possibly affecting treatment for prostate enlargement.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

MK-386 lowers DHT in blood and skin but not in semen.

Androgen receptors play a key role in male development and prostate cancer, with treatments targeting androgen action.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

5alpha-reductase inhibitors help treat hair loss and prostate issues but may cause sexual side effects.